Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells
Nature Biotechnology, Published online: 17 August 2026; doi:10.1038/s41587-026-03258-2 Primary human myeloid cells are efficiently edited using virus-like particles.
We haven't written up this one. Nature Biotechnology has the full story — the link below goes straight to it.